Anaphylaxis News

SAN DIEGO — About a third of adults with anaphylaxis due to food allergy have visited the ED for their allergy before, with asthma, age and cardiovascular disease associated with severe cases, according to a pair of posters presented here.

SAN DIEGO — College students with food allergies may find difficulty in finding ingredient labeling and emergency epinephrine access in dining halls, according to a presentation here.

The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 years and older, according to a press release from ARS Pharma.

SAN DIEGO — A retrospective chart review of patients with allergy who participated in subcutaneous immunotherapy and oral food challenges suggested that these therapies should be expanded, according to a pair of posters presented here.

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with two cartons of the company’s neffy epinephrine nasal spray, including a total of four single-use doses, for free.

BOSTON — Patients who were taking lipid-lowering medications experienced more severe anaphylaxis after insect stings, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Children with anaphylaxis who received epinephrine before going to the ED were significantly less likely to be admitted to the ICU, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is associated with a risk for anaphylaxis and issued a new boxed warning, according to a drug safety communication.

The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions manufactured by BPI Labs LLC and Endo USA.